Scheetz MH - Search Results

1

Effect of on-call infectious-diseases pharmacists on antibiotic expenditures.

Scheetz MH, Postelnick MJ, Scarsi KK, Gerzenshtein L, Bolon MK, Fotis M, Noskin GA. Scheetz MH, et al. Am J Health Syst Pharm. 2005 Oct 1;62(19):1967-8. doi: 10.2146/ajhp050033. Am J Health Syst Pharm. 2005. PMID: 16174825 No abstract available.

2

In vivo synergy of daptomycin plus a penicillin agent for MRSA?

Scheetz M, Reddy P, Postelnick M, Flaherty J. Scheetz M, et al. J Antimicrob Chemother. 2005 Mar;55(3):398-9. doi: 10.1093/jac/dkh554. Epub 2005 Jan 28. J Antimicrob Chemother. 2005. PMID: 15681583 No abstract available.

3

Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemia.

Scheetz MH, Bolon MK, Scarsi KK, Fotis MA, Postelnick MJ. Scheetz MH, et al. J Infect. 2006 Feb;52(2):105-10. doi: 10.1016/j.jinf.2005.03.007. J Infect. 2006. PMID: 15904961

4

Adjustment of antimicrobial dosages for continuous venovenous hemofiltration based on patient-specific information.

Scheetz MH, Scarsi KK, Ghossein C, Hurt KM, Zembower TR, Postelnick MJ. Scheetz MH, et al. Clin Infect Dis. 2006 Feb 1;42(3):436-7; author reply 437-8. doi: 10.1086/499535. Clin Infect Dis. 2006. PMID: 16392098 No abstract available.

5

Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.

Scheetz MH, Wunderink RG, Postelnick MJ, Noskin GA. Scheetz MH, et al. Pharmacotherapy. 2006 Apr;26(4):539-50. doi: 10.1592/phco.26.4.539. Pharmacotherapy. 2006. PMID: 16553514 Review.

6

Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens.

Scheetz MH, Hurt KM, Noskin GA, Oliphant CM. Scheetz MH, et al. Am J Health Syst Pharm. 2006 Jul 15;63(14):1346-60. doi: 10.2146/ajhp050403. Am J Health Syst Pharm. 2006. PMID: 16809756 Review.

7

The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.

Scheetz MH, Qi C, Noskin GA, Warren JR, Postelnick MJ, Malczynski M, Huang J, Zembower TR. Scheetz MH, et al. Diagn Microbiol Infect Dis. 2006 Dec;56(4):407-13. doi: 10.1016/j.diagmicrobio.2006.06.018. Epub 2006 Aug 23. Diagn Microbiol Infect Dis. 2006. PMID: 16930924

8

Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay.

Scarsi KK, Feinglass JM, Scheetz MH, Postelnick MJ, Bolon MK, Noskin GA. Scarsi KK, et al. Among authors: scheetz mh. Antimicrob Agents Chemother. 2006 Oct;50(10):3355-60. doi: 10.1128/AAC.00466-06. Antimicrob Agents Chemother. 2006. PMID: 17005817 Free PMC article.

9

Peritoneal fluid penetration of tigecycline.

Scheetz MH, Reddy P, Nicolau DP, Noskin GA, Postelnick MJ, Stosor V, Zembower TR. Scheetz MH, et al. Ann Pharmacother. 2006 Nov;40(11):2064-7. doi: 10.1345/aph.1H229. Epub 2006 Oct 17. Ann Pharmacother. 2006. PMID: 17047138

10

In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.

Scheetz MH, Qi C, Warren JR, Postelnick MJ, Zembower T, Obias A, Noskin GA. Scheetz MH, et al. Antimicrob Agents Chemother. 2007 May;51(5):1621-6. doi: 10.1128/AAC.01099-06. Epub 2007 Feb 16. Antimicrob Agents Chemother. 2007. PMID: 17307973 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters